Congress Day 4. Join us for the final CME session for discussion of PCSK9 lowering and LDL-C reduction.


17:30-19:00 CET
Lowering circulating PCSK9 to reduce LDL cholesterol: Current approaches
Chairs: Alberico L. Catapano, Italy & Lale Tokgözoglu, Turkey

  • The biology of PCSK9, Bertrand Cariou, Nantes, France
  • Monoclonal antibody approaches targeting circulating PCSK9, Ulf Landmesser, Berlin, Germany
  • siRNA based approaches targeting hepatic synthesis of PCSK9, Kausik Ray, London, UK
  • Panel discussion, with live Q&A


Plan your programme in the congress app or use the full interactive Programme web app if you are on a computer. The mobile and web apps sync, if you are logged in, so you can keep track of your programme at any time.